These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 24283197)

  • 21. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.
    Moazami N; Milano CA; John R; Sun B; Adamson RM; Pagani FD; Smedira N; Slaughter MS; Farrar DJ; Frazier OH;
    Ann Thorac Surg; 2013 Feb; 95(2):500-5. PubMed ID: 23261114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
    Joyce E; Stewart GC; Hickey M; Coakley L; Rivero JM; Gosev I; Givertz MM; Couper GS; Mehra MR
    J Heart Lung Transplant; 2015 Dec; 34(12):1561-9. PubMed ID: 26508725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.
    Gordon JS; Wood CT; Luc JGY; Watson RA; Maynes EJ; Choi JH; Morris RJ; Massey HT; Throckmorton AL; Tchantchaleishvili V
    Artif Organs; 2020 Mar; 44(3):231-238. PubMed ID: 31494952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel thrombosis risk index as predictor of left ventricular assist device thrombosis.
    Trivedi JR; Sobieski MA; Schwartz S; Williams ML; Slaughter MS
    ASAIO J; 2013; 59(4):380-3. PubMed ID: 23820276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumatic pulsatile ventricular assist device as a bridge to heart transplantation in pediatric patients.
    Amodeo A; Brancaccio G; Michielon G; Filippelli S; Ricci Z; Morelli S; Gagliardi MG; Iacobelli R; Pongiglione G; Di Donato RM
    Artif Organs; 2010 Nov; 34(11):1017-22. PubMed ID: 21092045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Courses of HeartMate II Left Ventricular Assist Device Thrombosis.
    Kittipibul V; Xanthopoulos A; Hurst TE; Fukamachi K; Blackstone EH; Soltesz E; Starling RC
    ASAIO J; 2020 Feb; 66(2):153-159. PubMed ID: 30688690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
    Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.
    Kirklin JK; Naftel DC; Pagani FD; Kormos RL; Myers S; Acker MA; Rogers J; Slaughter MS; Stevenson LW
    J Heart Lung Transplant; 2015 Dec; 34(12):1515-26. PubMed ID: 26681121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
    Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
    J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
    Dang NC; Topkara VK; Kim BT; Mercando ML; Kay J; Naka Y
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1302-9. PubMed ID: 16256782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolysis from aortic regurgitation mimicking pump thrombosis in a patient with a HeartMate II left ventricular assist device: a case report.
    Gopalan RS; Arabia FA; Noel P; Chandrasekaran K
    ASAIO J; 2012; 58(3):278-80. PubMed ID: 22285976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.